Literature DB >> 22185126

Substituted 2,3-Dihydro-4(1H)-quinazolinones. A New Class of Inhibitors of Cell Multiplication.

H L Yale, M Kalkstein.   

Abstract

Entities:  

Year:  1967        PMID： 22185126     DOI： 10.1021/jm00315a010

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  6 in total

Review 1.  2,3-Dihydroquinazolin-4(1H)-one as a privileged scaffold in drug design.

Authors:  Mariateresa Badolato; Francesca Aiello; Nouri Neamati
Journal:  RSC Adv       Date:  2018-06-07       Impact factor: 4.036

2.  Antibacterial activity of some 3-(arylideneamino)-2-phenylquinazoline-4(3H)-ones: synthesis and preliminary QSAR studies.

Authors:  Ashis Kumar Nanda; Subarna Ganguli; Ranadhir Chakraborty
Journal:  Molecules       Date:  2007-10-30       Impact factor: 4.411

Review 3.  Recent advances in the pharmacological diversification of quinazoline/quinazolinone hybrids.

Authors:  Prashant S Auti; Ginson George; Atish T Paul
Journal:  RSC Adv       Date:  2020-11-12       Impact factor: 4.036

4.  A novel dihydro phenylquinazolinone-based two-in-one colourimetric chemosensor for nickel(ii), copper(ii) and its copper complex for the fluorescent colourimetric nanomolar detection of the cyanide anion.

Authors:  Meman Sahu; Amit Kumar Manna; Shubhamoy Chowdhury; Goutam Kumar Patra
Journal:  RSC Adv       Date:  2020-12-21       Impact factor: 4.036

5.  Synthesis of a Pyrrolo[1,2-a]quinazoline-1,5-dione Derivative by Mechanochemical Double Cyclocondensation Cascade.

Authors:  Vanessza Judit Kolcsár; György Szőllősi
Journal:  Molecules       Date:  2022-09-02       Impact factor: 4.927

6.  Common pharmacophore of structurally distinct small-molecule inhibitors of intracellular retrograde trafficking of ribosome inactivating proteins.

Authors:  Shichao Yu; Jewn Giew Park; Jennifer Nielsen Kahn; Nilgun E Tumer; Yuan-Ping Pang
Journal:  Sci Rep       Date:  2013-12-02       Impact factor: 4.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.